Danaher Corporation against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-09-23T20:03:45+00:00 UTC · updates daily
MRNA leads 4 of the 5 windows we measure — over 1 month DHR is +3.0% and MRNA +31.1%; over year to date DHR is -3.2% and MRNA +517.5%. The DHR/MRNA price ratio stands at 1.2166, below its 50-day average of 2.3895, and below the 200-day average of 3.9277. A ratio above its own average means DHR is gaining on MRNA; on this reading the recent edge belongs to MRNA.
| DHR | MRNA | |
|---|---|---|
| Price | $221.56 | $182.11 |
| 1 day | +0.2%lead | -0.2% |
| 5 days | +6.3% | +25.1%lead |
| 1 month | +3.0% | +31.1%lead |
| 6 months | +16.6% | +255.1%lead |
| Year to date | -3.2% | +517.5%lead |
| 52-week position | 74% of range | 94% of range |
| 52-week range | $160.93–$242.80 | $22.28–$192.31 |
| vs 50-day average | above $205.04 | above $104.86 |
| vs 200-day average | above $201.82 | above $62.57 |
| RSI (14) | 66 | 70 |
| Next earnings | 2026-10-21 | 2026-11-05 |
DHR trades at $221.56, above its 50-day average of $205.04, and above the 200-day at $201.82. It sits at 74% of its 52-week range ($160.93–$242.80); 14-day RSI is 66, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $225.00 (1.6% away) and the first support below is $209.63 (5.4% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA trades at $182.11, above its 50-day average of $104.86, and above the 200-day at $62.57. It sits at 94% of its 52-week range ($22.28–$192.31); 14-day RSI is 70, in overbought territory; an average session moves it about 6.3%. For levels, the first level overhead is $182.56 (0.2% away) and the first support below is $175.00 (3.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 6.3% against 2.5% for DHR, so an identical position size carries roughly 2.5× the daily risk.
The comparison turns on those levels: DHR clearing $225.00 or losing $209.63; MRNA clearing $182.56 or losing $175.00. Until one of them gives way, the relative reading above stands.